1. Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy. (November 2022) Authors: Selim, Rania; Wellens, Judith; Brann, Stephanie; Marlow, Luke; Adams, Alex; Satsangi, Jack J Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 11(2022) Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease. (June 2022) Authors: Wellens, Judith; Brann, Stephanie; Adams, Alex; Marlow, Luke; Lindsay, James O; Satsangi, Jack J Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 6(2022) Page Start: 507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges. (15th March 2021) Authors: Wellens, Judith; Colombel, Jean-Frédéric; Satsangi, Jack J; Wong, Serre-Yu Journal: Journal of Crohn's and colitis Issue: Volume 15:Number 8(2021) Page Start: 1376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy. (December 2021) Authors: Selim, Rania; Wellens, Judith; Marlow, Luke; Satsangi, Jack J Journal: Lancet gastroenterology and hepatology Issue: Volume 6:Number 12(2021) Page Start: 989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗